Phibro Animal Health (PAHC) Change in Inventory (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Change in Inventory came in at $19.3 million in Q1 2026, up 40.75% year-on-year from $13.7 million in Q1 2025, and down 58.9% quarter-over-quarter from $47.0 million in Q4 2025.
Phibro Animal Health (PAHC) Change in Inventory (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Inventory history runs 14 years deep, the most recent figure standing at $19.3 million for Q1 2026.
- On a quarterly basis, Change in Inventory rose 40.75% year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $98.7 million, a 233.44% increase from a year earlier, with the FY2025 full-year figure at $44.3 million, up 1777.17% from the prior year.
- Change in Inventory fell to $19.3 million in Q1 2026 per PAHC's latest filing, from $47.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $47.0 million in Q4 2025 and bottomed at -$19.2 million in Q2 2023.
- The 5-year median for Change in Inventory is $6.2 million (2025), against an average of $10.0 million.
- Across the five-year window, Change in Inventory sank 220.28% in 2024 and jumped 929.73% in 2025, its largest moves.
- Year by year, Change in Inventory stood at $4.1 million in 2022, then tumbled by 38.1% to $2.5 million in 2023, then soared by 657.06% to $19.2 million in 2024, then surged by 144.49% to $47.0 million in 2025, then slumped by 58.9% to $19.3 million in 2026.
- Per Business Quant, the three latest PAHC Change in Inventory figures stand at $19.3 million (Q1 2026), $47.0 million (Q4 2025), and $26.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 19.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.33 Mn |
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | 47.03 Mn |
| Dec 31, 2025 | 47.03 Mn |
| Sep 30, 2025 | 26.18 Mn |
| Sep 30, 2025 | 26.18 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 13.73 Mn |
| Mar 31, 2025 | 13.73 Mn |
| Dec 31, 2024 | 19.24 Mn |
| Dec 31, 2024 | 19.24 Mn |
| Sep 30, 2024 | 5.16 Mn |
| Sep 30, 2024 | 5.16 Mn |
| Jun 30, 2024 | -8.53 Mn |
| Jun 30, 2024 | -8.53 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Dec 31, 2023 | 2.54 Mn |